Imdevimab - Research Grade Biosimilar, CAS [[2415933-40-1]], Unconjugated, Monoclonal
Artikelnummer:
PRS-21-920
Artikelname: |
Imdevimab - Research Grade Biosimilar, CAS [[2415933-40-1]], Unconjugated, Monoclonal |
Artikelnummer: |
PRS-21-920 |
Hersteller Artikelnummer: |
21-920 |
Alternativnummer: |
PRS-21-920-0.1 |
Hersteller: |
ProSci |
Kategorie: |
Antikörper |
Immunogen: |
Homo sapiens / SARS-CoV-2 Spike RBD |
Konjugation: |
Unconjugated |
Alternative Synonym: |
IMDEVIMAB, IMDEVIMAB [INN], IMDEVIMAB [USAN], IMDEVIMAB [WHO-DD], IMMUNOGLOBULIN G1, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN) (HUMAN MONOCLONAL REGN10987 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN10987 .LAMBDA. |
Klonalität: |
Monoclonal |
Konzentration: |
batch dependent |
NCBI: |
43740568 |
UniProt: |
P0DTC2 |
Puffer: |
PBS buffer pH 7.5 |
Quelle: |
CHO cells |
Reinheit: |
>95% |
CAS Nummer: |
[2415933-40-1] |
Application Verdünnung: |
For research use only . |